"Cardiorisk" extended profile
A comprehensive set of laboratory tests for an extended assessment of the cardiovascular system, lipid and carbohydrate metabolism, kidney function, electrolyte balance, and risk factors for atherosclerotic cardiovascular diseases.
The package combines markers from several interrelated areas: atherogenic risk, myocardial injury and workload, metabolic disorders, and kidney function. This approach allows for a comprehensive assessment of the patient's cardiorenal-metabolic profile and identification of factors that may increase the likelihood of cardiovascular complications.
The package includes:
- Triglycerides
- Total cholesterol
- HDL cholesterol
- LDL cholesterol
- Apolipoprotein A1
- Apolipoprotein B
- High-sensitivity C-reactive protein, Cardio
- Troponin I
- Lipoprotein (a)
- Atherogenic index
- Glycated hemoglobin (HbA1c)
- Cystatin C
- Potassium (K) in blood
- Calcium (Ca) in blood
- Sodium (Na) in blood
- Uric acid
- Urea
- Creatinine
- NT-proBNP
What does the package assess ?
The lipid profile, apolipoproteins, lipoprotein (a), and atherogenic index are used for a comprehensive assessment of lipid metabolism disorders and atherosclerotic cardiovascular risk.
Apolipoprotein B measurement additionally characterizes the number of atherogenic lipoprotein particles, while lipoprotein (a) helps identify a predominantly genetically determined cardiovascular risk factor.
High-sensitivity C-reactive protein reflects the level of low-grade systemic inflammation and may be used as an additional marker of cardiovascular risk.
Troponin I is a marker of cardiomyocyte injury. An elevated level requires clinical assessment taking into account symptoms, changes in the marker over time, and other examination results.
NT-proBNP reflects hemodynamic stress on the myocardium and is used in the diagnosis and assessment of patients with suspected heart failure.
Glycated hemoglobin reflects the average blood glucose level over approximately the previous 2-3 months and is used to detect and monitor carbohydrate metabolism disorders.
Creatinine, cystatin C, and urea allow assessment of kidney function. Cystatin C may be used for an additional assessment of glomerular filtration rate, particularly in situations where creatinine concentration may not accurately reflect kidney function.
Uric acid helps identify hyperuricemia, which is frequently associated with metabolic disorders, arterial hypertension, and chronic kidney disease.
Potassium, sodium, and calcium are essential for assessing electrolyte balance, which is important for normal cardiovascular function, neuromuscular conduction, and monitoring patients receiving diuretics and other medications.